Skip to main content
Industry News
Specialty pharmacists optimize rare disease treatment

The Orphan Drug Act of 1983 incentivized the pharmaceutical industry to develop drugs for rare diseases, which are now among the highest-priced drugs on the market. Specialty pharmacists can optimize treatment by providing proactive, holistic management that can improve outcomes and lower costs, according to pharmacist Brandeis Seymore.

Full Story: